SCHEMBL14066331

SCHEMBL14066331

COP(=O)(OC)C(c1ccc(F)cc1)(c1ccc(Cl)cc1)c1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.40
KCNE1 P15382 1/20 0.39
KCNQ1 P51787 1/20 0.39
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CYP19A1 P11511 4/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MLNR O43193 1/20 0.33
NR1I2 O75469 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
TBXA2R P21731 1/20 0.33
CCKBR P32239 1/20 0.33
OPRK1 P41145 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33
NR1H4 Q96RI1 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1508011 0.93 KCNN4 (0.45) KCNN4KCNE1KCNQ1CYP1A2CYP2C9
SCHEMBL1508145 0.88 KCNN4 (0.40) KCNN4KCNE1KCNQ1CYP19A1SMN1; SMN2
SCHEMBL1508253 0.85 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19CYP19A1L3MBTL1
SCHEMBL1507954 0.77 KCNN4 (0.36) KCNN4CYP1A2CYP2C19HTTSMN1; SMN2
SCHEMBL1508229 0.73 KCNN4 (0.53) KCNN4KCNE1KCNQ1MLNRNR1I2
SCHEMBL6622435 0.72 KCNN4 (0.46) KCNN4KCNE1KCNQ1CYP19A1MLNR
SCHEMBL1508012 0.70 KCNN4 (0.47) KCNN4KCNE1KCNQ1NR1I2LMNA
SCHEMBL1508149 0.70 KCNN4 (0.41) KCNN4KCNE1KCNQ1CYP19A1SMN1; SMN2
SCHEMBL1508216 0.70 KCNN4 (0.45) KCNN4CYP19A1SMN1; SMN2LMNAHDAC6
SCHEMBL1508091 0.69 HDAC6 (0.41) L3MBTL1SMN1; SMN2MAPTHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429618-B2 Potassium channel modulators NEUROSEARCH A/S (DK) 2008-09-30 US disclosed
US-7429618-B2 Potassium channel modulators NEUROSEARCH A/S (DK) 2008-09-30 US disclosed
US-20070161607-A1 Potassium channel modulators SANIONA A/S (DK) 2007-07-12 US disclosed
US-20070161607-A1 Potassium channel modulators SANIONA A/S (DK) 2007-07-12 US disclosed
US-7208527-B2 Potassium channel modulators POSEIDON PHARMACEUTICALS A/S (DK) 2007-04-24 US disclosed
US-7208527-B2 Potassium channel modulators POSEIDON PHARMACEUTICALS A/S (DK) 2007-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161607-A1 Potassium channel modulators KCNC1, KCNQ1, KCNA1 KCNN4 48/4885KCNE1 29/4885KCNQ1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.